Yokohama, Japan

Eitaroh Morita

This inventor holds 2 USPTO granted patents. Top assignee: Nippon Oil Company. Active years: 1993-1994.


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 1993-1994

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Eitaroh Morita: Innovator in Podophyllotoxin Production

Introduction

Eitaroh Morita is a notable inventor based in Yokohama, Japan. He has made significant contributions to the field of plant biotechnology, particularly in the production of podophyllotoxins. With a total of 2 patents, Morita's work has implications for both medicine and agriculture.

Latest Patents

Morita's latest patents focus on innovative processes for the production of podophyllotoxins using plants from the genus Podophyllum. One of his patents describes a method for preparing an adventive embryo of Podophyllum, which involves incubating plant cells in a sugar-free medium and then in a medium with higher sugar content. Another patent outlines a process for producing podophyllotoxin compounds by culturing adventive embryos to generate adventitious organs, which are then cultured to produce the desired compounds. These processes highlight Morita's expertise in plant tissue culture and compound extraction.

Career Highlights

Eitaroh Morita is currently associated with Nippon Oil Company, where he applies his knowledge in plant biotechnology to advance the company's research initiatives. His work has been instrumental in developing methods that enhance the efficiency of podophyllotoxin production, which is crucial for pharmaceutical applications.

Collaborations

Morita has collaborated with notable colleagues such as Ko Sakata and Tetsuya Takezono. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas in the field of plant biotechnology.

Conclusion

Eitaroh Morita's contributions to the production of podophyllotoxins through innovative processes demonstrate his commitment to advancing plant biotechnology. His work not only enhances our understanding of plant tissue culture but also has significant implications for the pharmaceutical industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…